NCT07222345

Brief Summary

This pilot study evaluates the feasibility of a 12-week high intensity interval training (HIIT) program in survivors of childhood, adolescent, and young adult Hodgkin lymphoma within 24 months of completing treatment. Preliminary efficacy of the HIIT intervention for improved cardiorespiratory fitness, body composition, physical function, autonomic response to exercise, peripheral neuropathy, biological aging markers, and physical activity will also be evaluated. Primary Objective: To determine the feasibility of a 12-week high intensity interval training (HIIT) program in survivors of childhood, adolescent, and young adult Hodgkin lymphoma within 24 months of completing treatment. Feasibility will be assessed by:

  • Participation Rate: Number of eligible survivors approached who enroll.
  • Completion Rate: Number of scheduled HIIT sessions attended and number of enrolled participants who complete post-intervention testing.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
33mo left

Started Apr 2026

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress4%
Apr 2026Jan 2029

First Submitted

Initial submission to the registry

October 27, 2025

Completed
2 days until next milestone

First Posted

Study publicly available on registry

October 29, 2025

Completed
5 months until next milestone

Study Start

First participant enrolled

April 1, 2026

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2028

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2029

Last Updated

April 23, 2026

Status Verified

April 1, 2026

Enrollment Period

1.8 years

First QC Date

October 27, 2025

Last Update Submit

April 21, 2026

Conditions

Keywords

Childhood Cancer Survivor

Outcome Measures

Primary Outcomes (2)

  • Participation rate (percent of eligible participants approached who enroll)

    Descriptive statistics will be reported

    Trial completion (12 weeks)

  • Completion rate (percentage of scheduled HIIT sessions attended and percentage of post-intervention testing sessions completed)

    Descriptive statistics will be reported

    Trial completion (12 weeks)

Other Outcomes (15)

  • Cardiorespiratory fitness (VO2peak, ml/kg/min)

    baseline at study entry, 12 weeks

  • Ewing battery score of autonomic function (0 to 5 points)

    baseline at study entry, 12 weeks

  • Body mass index (weight and height will be combined to report body mass index in kg/m2)

    baseline at study entry, 12 weeks

  • +12 more other outcomes

Study Arms (1)

HIIT Intervention Group

EXPERIMENTAL

Participants will complete a 12-week HIIT program with three 25-minute sessions per week. Each session includes warm-up, five cycles of high-intensity intervals (80-95% peak HR) and recovery periods (50-60% peak HR), and cool-down.

Behavioral: High Intensity Interval Training (HIIT)

Interventions

Participants will complete a 12-week HIIT program with three 25-minute sessions per week. Each session includes warm-up, five cycles of high-intensity intervals (80-95% peak HR) and recovery periods (50-60% peak HR), and cool-down.

HIIT Intervention Group

Eligibility Criteria

Age10 Years - 25 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Participant has been diagnosed with Hodgkin lymphoma between the ages of 10 to 25 years.
  • Participant is between the ages of \>10 and \<25 years old the time of enrollment.
  • Participant has completed treatment (end of chemotherapy for those not receiving radiation therapy or end of radiation therapy) for Hodgkin lymphoma within 24 months prior to enrollment and recovered from any acute treatment-related adverse events.
  • Participant has been medically cleared to participate in physical activity.
  • Participant verbalizes understanding of directions for use of the web-based platform on the study provided iPad and heart rate monitor.

You may not qualify if:

  • Participant has evidence of relapsed disease.
  • Participant has a diagnosis of acute heart failure.
  • Participant reports currently participating in HIIT training or \>420 minutes per week of moderate to vigorous physical activity.
  • Female participant who is currently pregnant.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

St. Jude Children's Research Hospital

Memphis, Tennessee, 38105, United States

RECRUITING

Related Links

MeSH Terms

Conditions

Hodgkin Disease

Interventions

High-Intensity Interval Training

Condition Hierarchy (Ancestors)

LymphomaNeoplasms by Histologic TypeNeoplasmsLymphoproliferative DisordersLymphatic DiseasesHemic and Lymphatic DiseasesImmunoproliferative DisordersImmune System Diseases

Intervention Hierarchy (Ancestors)

Physical Conditioning, HumanExerciseMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Amy Berkman, MD

    St. Jude Children's Research Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 27, 2025

First Posted

October 29, 2025

Study Start

April 1, 2026

Primary Completion (Estimated)

January 1, 2028

Study Completion (Estimated)

January 1, 2029

Last Updated

April 23, 2026

Record last verified: 2026-04

Locations